UK – Abbott’s wearable glucose monitor to be available across England

FreeStyle Libre will be prescribed to those with T1 diabetes Patients with type 1 diabetes across England will soon be able to access Abbott's FreeStyle Libre wearable glucose sensor, a device that was only previously offered to those living in certain areas of the country.

Following an investigation from the BMJ earlier this year, it was found that a quarter of local NHS Clinical Commissioning Groups (CCGs) in England did not provide the technology for patients, mainly due to funding limitations.

Dubbed the ‘postcode lottery’, NHS England’s chief executive Simon Stevens says it will now direct all areas to make it more widely available.

By April next year, all type 1 diabetes patients (who qualifies in line with clinical guidelines) will have access to the tech on prescription, he says.

Simon Stevens said: “As the NHS prepares to put digital health and technology at the heart of our long term plan for the future, NHS England is taking important action so that regardless of where you live, if you’re a patient with Type 1 diabetes you can reap the benefits of this life improving technology.”…